SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.013
AS - Asia 5.073
EU - Europa 2.828
SA - Sud America 817
AF - Africa 108
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.827
SG - Singapore 1.831
CN - Cina 1.453
BR - Brasile 623
UA - Ucraina 606
VN - Vietnam 540
GB - Regno Unito 432
DE - Germania 424
HK - Hong Kong 399
TR - Turchia 348
IT - Italia 307
FR - Francia 200
PL - Polonia 183
FI - Finlandia 177
SE - Svezia 161
RU - Federazione Russa 128
JP - Giappone 106
IN - India 90
CA - Canada 83
MX - Messico 75
BD - Bangladesh 73
AR - Argentina 71
ZA - Sudafrica 52
IQ - Iraq 48
NL - Olanda 45
BE - Belgio 40
AT - Austria 36
EC - Ecuador 32
CO - Colombia 30
ES - Italia 27
ID - Indonesia 27
PK - Pakistan 23
VE - Venezuela 22
UZ - Uzbekistan 16
IR - Iran 14
LT - Lituania 14
CL - Cile 13
MA - Marocco 13
PH - Filippine 13
SA - Arabia Saudita 13
MY - Malesia 11
PY - Paraguay 11
KR - Corea 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
KE - Kenya 7
TN - Tunisia 7
CR - Costa Rica 6
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
BY - Bielorussia 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
CH - Svizzera 4
JO - Giordania 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
MZ - Mozambico 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
IE - Irlanda 1
Totale 18.844
Salva come PNG Salva come JPEG
Città #
Singapore 1.228
Ashburn 1.066
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 605
San Jose 569
Chandler 504
Ann Arbor 458
Beijing 457
Santa Clara 409
Hong Kong 393
Seattle 336
Wilmington 331
Cambridge 283
New York 218
Nanjing 194
Izmir 188
Warsaw 172
Ho Chi Minh City 152
Los Angeles 152
Hanoi 144
Princeton 134
Dallas 128
Tokyo 100
Lauterbourg 97
San Diego 87
Buffalo 79
Munich 78
São Paulo 65
Boardman 61
Milan 60
Shanghai 58
Shenyang 58
Mexico City 51
Orem 51
Tianjin 51
Helsinki 48
Nanchang 47
Brussels 39
Hefei 39
Chicago 38
Hebei 38
Frankfurt am Main 37
Jiaxing 37
The Dalles 37
San Mateo 34
Ferrara 32
Vienna 30
Toronto 29
Da Nang 28
Brooklyn 27
Changsha 27
London 27
Chennai 26
Montreal 25
Council Bluffs 24
Jinan 24
Johannesburg 23
Ningbo 23
Baghdad 21
Guangzhou 20
Norwalk 20
Philadelphia 20
Poplar 20
San Francisco 20
Stockholm 20
Washington 20
Denver 19
Falls Church 19
Moscow 19
Rio de Janeiro 19
Boston 18
Mountain View 17
Turku 17
Ankara 16
Hải Dương 16
Amsterdam 15
Augusta 15
Dearborn 15
Kunming 15
Leawood 15
Manchester 15
Auburn Hills 14
Haiphong 14
Atlanta 13
Medellín 13
Phoenix 13
Tashkent 13
Belo Horizonte 12
Biên Hòa 12
Falkenstein 12
Mumbai 12
Orange 12
Verona 12
Zhengzhou 12
Caracas 11
Curitiba 11
Redwood City 11
Taizhou 11
Totale 12.726
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 315
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 268
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 266
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 262
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 257
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 248
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 243
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 240
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 239
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 233
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 224
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 221
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 221
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 211
HSV as a vector in vaccine development and gene therapy 210
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 205
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 199
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 198
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 198
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 197
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 196
Herpesvirus-based vaccines 196
Replication-competent herpes simplex vectors: design and applications 196
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 194
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 192
Capitolo 55 Retrovirus 191
HSV as a vector in vaccine development and gene therapy 190
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 188
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 185
Herpes Simplex Virus Growth, Preparation, and Assay 184
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 182
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 181
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 180
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 179
null 179
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 173
Purinergic Signaling: A New Pharmacological Target Against Viruses? 173
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 171
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 168
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 167
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 165
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 165
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 164
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 164
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 163
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 162
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 162
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 162
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 161
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 160
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 158
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 156
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 155
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 155
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 154
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 152
Herpesvirus/retrovirus chimeric vectors 151
Capitolo 44 Herpesviridae 151
State of viral DNA in BK virus-transformed rabbit cells 150
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 148
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 146
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 146
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 145
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 145
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 143
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 142
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 142
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 140
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 140
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 139
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 139
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 136
HSV-1 virions engineered for specific binding to cell surface receptors 133
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 132
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 130
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 128
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 124
Transformation by defined regions of herpes simplex virus DNA. 123
HSV Recombinant Vectors for Gene Therapy 122
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 121
Molecular diagnosis of herpes simplex encephalitis 121
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 119
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 119
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 118
Niosomes for vaginal administration of an antiherpetic peptide 117
Gene therapy of the nervous system by herpes virus vectors 115
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 113
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale. 112
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 110
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 110
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 109
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 108
Niosomes containing HSV immunogens as possible vaccine against genital herpes 108
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 108
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 107
null 107
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 105
null 104
null 104
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 103
Totale 16.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.254
Totale 83.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021477 0 0 0 0 0 0 0 0 0 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20266.675 755 273 643 959 1.054 496 761 357 666 711 0 0
Totale 18.951